Clearside Biomedical, Inc.
CLSDDelisted Dec 8, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001539029
Clearside Biomedical, Inc. was delisted on Dec 8, 2025; its insiders filed their last Form 4 on Feb 24, 2025; 26 institutions reported holding it in 13F filings for Q3 2025, worth $2.18M in total; no superinvestor held it.
13F holders, Q3 2025
Institutional positions in Clearside Biomedical, Inc. as of Sep 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 26
- −18 vs. Q2 2025
- Shares held
- 552.5K
- −67.0K (−10.8%) vs. Q2 2025Converted for a 1-for-15 split
- Total value
- $2.18M
- −$5.25M (−70.6%) vs. Q2 2025
- New holders
- 6
- 2 more added
- Sold out
- 24
- 10 more reduced
1 institution that held it in Q2 2025 haven't filed for Q3 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CLSD on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 1 | $3.26K |
| Q1 2026 | 1 | $7.87K |
| Q4 2025 | 1 | $19.1K |
| Q3 2025 | 26 | $2.18M |
| Q2 2025 | 45 | $7.51M |
| Q1 2025 | 44 | $8.09M |
| Q4 2024 | 44 | $8.97M |
| Q3 2024 | 49 | $12.7M |
| Q2 2024 | 49 | $17.9M |
| Q1 2024 | 52 | $23.8M |
| Q4 2023 | 48 | $9.06M |
| Q3 2023 | 46 | $6.82M |
| Q2 2023 | 54 | $9.62M |
| Q1 2023 | 51 | $9.09M |
| Q4 2022 | 53 | $10.2M |
| Q3 2022 | 54 | $13.6M |
| Q2 2022 | 53 | $20.1M |
| Q1 2022 | 60 | $37.5M |
| Q4 2021 | 67 | $57.8M |
| Q3 2021 | 66 | $121.5M |
| Q2 2021 | 53 | $95.8M |
| Q1 2021 | 52 | $43.8M |
Institutions, Q3 2025
Shares, value and share of portfolio for each institution holding Clearside Biomedical, Inc.; share changes are against Q2 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 221,968 | $881.2K | 0.00% | −2,236−1.0% | ReducedConverted for a 1-for-15 split |
| Carmignac Gestion | 100,556 | $399.2K | 0.01% | 00.0% | UnchangedConverted for a 1-for-15 split |
| Geode Capital Management, LLC | 52,741 | $209.4K | 0.00% | 00.0% | UnchangedConverted for a 1-for-15 split |
| BlackRock, Inc. | 41,677 | $165.5K | 0.00% | 00.0% | UnchangedConverted for a 1-for-15 split |
| Renaissance Technologies LLC | 25,247 | $100.2K | 0.00% | −7,859−23.7% | ReducedConverted for a 1-for-15 split |
| Apollon Wealth Management, LLC | 23,586 | $93.6K | 0.00% | +23,586 | New |
| First Manhattan Co | 22,846 | $90.7K | 0.00% | 00.0% | UnchangedConverted for a 1-for-15 split |
| State Street Corp | 16,387 | $65.1K | 0.00% | −1,297−7.3% | ReducedConverted for a 1-for-15 split |
| Gsa Capital Partners LLP | 12,885 | $51.0K | 0.00% | −22,683−63.8% | ReducedConverted for a 1-for-15 split |
| Northern Trust Corp | 11,032 | $43.8K | 0.00% | 00.0% | UnchangedConverted for a 1-for-15 split |
| UBS Group AG | 9,303 | $36.9K | 0.00% | +7,135+329.2% | AddedConverted for a 1-for-15 split |
| The PNC Financial Services Group, Inc. | 7,194 | $28.6K | 0.00% | 00.0% | UnchangedConverted for a 1-for-15 split |
| New Millennium Group LLC | 2,952 | $11.7K | 0.01% | +2,952 | New |
| Morgan Stanley | 750 | $2.98K | 0.00% | −7,976−91.4% | ReducedConverted for a 1-for-15 split |
| Wells Fargo & Company | 400 | $1.59K | 0.00% | 00.0% | UnchangedConverted for a 1-for-15 split |
| Advisor Group Holdings, Inc. | 2,500 | $900 | 0.00% | +2,320+1,286.3% | AddedConverted for a 1-for-15 split |
| Bank of America Corp | 118 | $469 | 0.00% | −26−18.3% | ReducedConverted for a 1-for-15 split |
| FMR LLC | 83 | $330 | 0.00% | +83 | New |
| CIBC Private Wealth Group, LLC | 73 | $290 | 0.00% | 00.0% | UnchangedConverted for a 1-for-15 split |
| Financial Consulate, Inc | 66 | $263 | 0.00% | +66 | New |
| SBI Securities Co., Ltd. | 51 | $202 | 0.00% | −1−2.2% | ReducedConverted for a 1-for-15 split |
| JPMorgan Chase & Co | 46 | $183 | 0.00% | −10−17.9% | ReducedConverted for a 1-for-15 split |
| Barclays PLC | 14 | $56 | 0.00% | +14 | New |
| Creative Financial Designs Inc | 6 | $24 | 0.00% | −1−10.0% | ReducedConverted for a 1-for-15 split |
| Allworth Financial LP | 3 | $12 | 0.00% | −0−10.0% | ReducedConverted for a 1-for-15 split |
| Citigroup Inc | 1 | $4 | 0.00% | +1 | New |
| Bridgeway Capital Management, LLC | 0 | $0 | 0.00% | −13,667−100.0% | Sold outConverted for a 1-for-15 split |
| Assenagon Asset Management S.A. | 0 | $0 | 0.00% | −8,794−100.0% | Sold outConverted for a 1-for-15 split |
| Brown Wealth Management, LLC | 0 | $0 | 0.00% | −6,667−100.0% | Sold outConverted for a 1-for-15 split |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −5,975−100.0% | Sold outConverted for a 1-for-15 split |
| Captrust Financial Advisors | 0 | $0 | 0.00% | −5,800−100.0% | Sold outConverted for a 1-for-15 split |
| Stifel Financial Corp | 0 | $0 | 0.00% | −2,663−100.0% | Sold outConverted for a 1-for-15 split |
| Investor's Fiduciary Advisor Network, LLC | 0 | $0 | 0.00% | −2,253−100.0% | Sold outConverted for a 1-for-15 split |
| Newman Dignan & Sheerar, Inc. | 0 | $0 | 0.00% | −2,008−100.0% | Sold outConverted for a 1-for-15 split |
| Synovus Financial Corp | 0 | $0 | 0.00% | −2,000−100.0% | Sold outConverted for a 1-for-15 split |
| PKS Advisory Services, LLC | 0 | $0 | 0.00% | −1,633−100.0% | Sold outConverted for a 1-for-15 split |
| Westmount Partners, LLC | 0 | $0 | 0.00% | −1,560−100.0% | Sold outConverted for a 1-for-15 split |
| Commonwealth Equity Services, LLC | 0 | $0 | 0.00% | −1,500−100.0% | Sold outConverted for a 1-for-15 split |
| Mariner, LLC | 0 | $0 | 0.00% | −1,263−100.0% | Sold outConverted for a 1-for-15 split |
| Warren Averett Asset Management, LLC | 0 | $0 | 0.00% | −1,225−100.0% | Sold outConverted for a 1-for-15 split |
| Oppenheimer & Co Inc | 0 | $0 | 0.00% | −956−100.0% | Sold outConverted for a 1-for-15 split |
| Stratos Wealth Advisors, LLC | 0 | $0 | 0.00% | −933−100.0% | Sold outConverted for a 1-for-15 split |
| Cambridge Investment Research Advisors, Inc. | 0 | $0 | 0.00% | −700−100.0% | Sold outConverted for a 1-for-15 split |
| Rockwood Wealth Management, LLC | 0 | $0 | 0.00% | −667−100.0% | Sold outConverted for a 1-for-15 split |
| Gen-Wealth Partners Inc | 0 | $0 | 0.00% | −667−100.0% | Sold outConverted for a 1-for-15 split |
| Royal Bank of Canada | 0 | $0 | 0.00% | −93−100.0% | Sold outConverted for a 1-for-15 split |
| Raymond James Financial Inc | 0 | $0 | 0.00% | −67−100.0% | Sold outConverted for a 1-for-15 split |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −54−100.0% | Sold outConverted for a 1-for-15 split |
| BNP Paribas Arbitrage, SA | 0 | $0 | 0.00% | −0−100.0% | Sold outConverted for a 1-for-15 split |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −8−100.0% | Sold outConverted for a 1-for-15 split |
| Northeast Financial Consultants Inc | – | – | – | – | Not filed |